Search
for
Sort by
Research 391–420 of 721
- Low Level Laser versus Platelet-rich Plasma in Treatment of Alopecia Areata: A Randomized Controlled Intra-patient Comparative Study
- Diagnosis and treatment of local forms of alopecia areata in children
- Common Causes of Hair Loss and Their Treatment Options
- Trichoscopy and Trichogram
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- A “hair‐raising” history of alopecia areata
- Novel potential therapeutic targets of alopecia areata
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Serum Zinc Concentration in Patients with Alopecia Areata
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Alopecia Areata: An Updated Review for 2023
- A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Alopecia Areata in the Elderly: A 10-Year Retrospective Study
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Oxidative stress and antioxidant markers in patients with alopecia areata: A comparative cross-sectional study